Localization of Nav 1.7 in the normal and injured rodent olfactory system indicates a critical role in olfaction, pheromone sensing and immune function

Channels

Volumn 6, Issue 2, 2012, Pages 103-110

  Rupasinghe, Darshani B ^a   Knapp, Oliver ^b   Blomster, Linda V ^a   Schmid, Annina B ^a   Adams, David J ^b   King, Glenn F ^a   Ruitenberg, Marc J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b RMIT UNIVERSITY   (Australia)

Author keywords

Inflammation; Injury; Monocyte; Pain; Regeneration; Sodium channel

Indexed keywords

PHEROMONE; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL 1.7; SCN9A PROTEIN, RAT; SODIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MALE; NEUROEPITHELIUM; NONHUMAN; OLFACTORY SYSTEM; PAIN; RAT; SENSORY NERVE CELL; SMELLING; VOMERONASAL ORGAN; ANIMAL; CHO CELL; CRICETULUS; CYTOLOGY; DRUG EFFECT; HAMSTER; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INNERVATION; METABOLISM; MONOCYTE; NERVE FIBER; ODOR; OLFACTORY BULB; OLFACTORY EPITHELIUM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS; RODENTIA;

ANIMALS; AXONS; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MONOCYTES; OLFACTORY BULB; OLFACTORY MUCOSA; RATS; RATS, SPRAGUE-DAWLEY; SMELL; SODIUM CHANNELS; VOMERONASAL ORGAN;

EID: 84861608752     PISSN: 19336950     EISSN: 19336969     Source Type: Journal    
DOI: 10.4161/chan.19484     Document Type: Article

References (37)

1. Yu FH, Catterall WA. Overview of the voltage-gated sodium channel family. Genome Biol 2003; 4:207; PMID:12620097; http://dx.doi.org/10.1186/gb-2003-4-3- 207.
2. King GF, Escoubas P, Nicholson GM. Peptide toxins that selectively target insect Na(V) and Ca(V) channels. Channels (Austin) 2008; 2:100-16; PMID:18849658; http://dx.doi.org/10.4161/chan.2.2.6022.
3. Waxman SG, Dib-Hajj S. Erythermalgia: molecular basis for an inherited pain syndrome. Trends Mol Med 2005; 11:555-62; PMID:16278094; http://dx.doi.org/10.1016/j.molmed.2005.10.004.
4. Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, Abrahamsen B, et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 2006; 52:767-74; PMID:17145499; http://dx.doi.org/10.1016/j.neuron.2006.10.006.
5. Cox JJ, Reimann F, Nicholas AK, Thornton G, Roberts E, Springell K, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 2006; 444:894-8; PMID:17167479; http://dx.doi.org/10.1038/nature05413.
6. Goldberg YP, MacFarlane J, MacDonald ML, Thompson J, Dube MP, Mattice M, et al. Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet 2007; 71:311-9; PMID:17470132; http://dx.doi.org/10.1111/j.1399-0004.2007.00790.x.
7. Reimann F, Cox JJ, Belfer I, Diatchenko L, Zaykin DV, McHale DP, et al. Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci USA 2010; 107:5148-53; PMID:20212137; http://dx.doi.org/10.1073/pnas. 0913181107.
8. v 1.7 and human pain disorders. Trends Neurosci 2007; 30:555-63; PMID:17950472; http://dx.doi.org/10.1016/j.tins.2007.08.004.
9. Krafte DS, Bannon AW. Sodium channels and nociception: recent concepts and therapeutic opportunities. Curr Opin Pharmacol 2008; 8:50-6; PMID:17964852; http://dx.doi.org/10.1016/j.coph.2007.09.007.
10. Momin A, Wood JN. Sensory neuron voltage-gated sodium channels as analgesic drug targets. Curr Opin Neurobiol 2008; 18:383-8; PMID:18824099; http://dx.doi.org/10.1016/j.conb.2008.08.017.
11. McGowan E, Hoyt SB, Li X, Lyons KA, Abbadie C. A peripherally acting Na(v)1.7 sodium channel blocker reverses hyperalgesia and allodynia on rat models of inflammatory and neuropathic pain. Anesth Analg 2009; 109:951-8; PMID:19690272; http://dx.doi.org/10.1213/ane.0b013e3181b01b02.
12. Priest BT. Future potential and status of selective sodium channel blockers for the treatment of pain. Curr Opin Drug Discov Devel 2009; 12:682-92; PMID:19736626.
13. Dib-Hajj SD, Black JA, Waxman SG. Voltage-gated sodium channels: therapeutic targets for pain. Pain Med 2009; 10:1260-9; PMID:19818036; http://dx.doi.org/10.1111/j.1526-4637.2009.00719.x.
14. Nilsen KB, Nicholas AK, Woods CG, Mellgren SI, Nebuchennykh M, Aasly J. Two novel SCN9A mutations causing insensitivity to pain. Pain 2009; 143:155-8; PMID:19304393; http://dx.doi.org/10.1016/j.pain.2009.02.016.
15. v1.7 cause anosmia. Nature 2011; 472:186-90; PMID:21441906; http://dx.doi.org/10.1038/nature09975.
16. Nassar MA, Levato A, Stirling LC, Wood JN. Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. Mol Pain 2005; 1:24; PMID:16111501; http://dx.doi.org/10.1186/1744-8069-1-24.
17. Brennan PA, Keverne EB. Something in the air? New insights into mammalian pheromones. Curr Biol 2004; 14:81-9; PMID:14738757; http://dx.doi.org/10.1016/ j.cub.2003.12.052.
18. Mombaerts P. Genes and ligands for odorant, vomeronasal and taste receptors. Nat Rev Neurosci 2004; 5:263-78; PMID:15034552; http://dx.doi.org/10. 1038/nrn1365.
19. Ramón y Cajal S. Histologie du systeme nerveux de l'homme et des vertébré. Paris: Maloine 1911.
20. Wachowiak M, Denk W, Friedrich RW. Functional organization of sensory input to the olfactory bulb glomerulus analyzed by two-photon calcium imaging. Proc Natl Acad Sci USA 2004; 101:9097-102; PMID:15184670; http://dx.doi.org/10. 1073/pnas.0400438101.
21. Li Y, Field PM, Raisman G. Olfactory ensheathing cells and olfactory nerve fibroblasts maintain continuous open channels for regrowth of olfactory nerve fibres. Glia 2005; 52:245-51; PMID:15968636; http://dx.doi.org/10.1002/ glia.20241.
22. Ruitenberg MJ, Vukovic J. Promoting central nervous system regeneration: lessons from cranial nerve I. Restor Neurol Neurosci 2008; 26:183-96; PMID:18820410.
23. Ahn HS, Black JA, Zhao P, Tyrrell L, Waxman SG, Dib-Hajj SD. Nav1.7 is the predominant sodium channel in rodent olfactory sensory neurons. Mol Pain 2011; 7:32; PMID:21569247; http://dx.doi.org/10.1186/1744-8069-7-32.
24. v1.7 maintains the membrane potential and regulates the activation and chemokine-induced migration of a monocyte-derived dendritic cell subset. J Immunol 2011; 187:1273-80; PMID:21715690; http://dx.doi.org/10.4049/jimmunol.1003345.
25. Vukovic J, Marmorstein LY, McLaughlin PJ, Sasaki T, Plant GW, Harvey AR, et al. Lack of fibulin-3 alters regenerative tissue responses in the primary olfactory pathway. Matrix Biol 2009; 28:406-15; PMID:19520159; http://dx.doi.org/10.1016/j.matbio. 2009.06.001.
26. Sakamoto T, Kondo K, Kashio A, Suzukawa K, Yamasoba T. Methimazole-induced cell death in rat olfactory receptor neurons occurs via apoptosis triggered through mitochondrial cytochrome c-mediated caspase-3 activation pathway. J Neurosci Res 2007; 85:548-57; PMID:17171702; http://dx.doi.org/10.1002/jnr.21155.
27. Leung CT, Coulombe PA, Reed RR. Contribution of olfactory neural stem cells to tissue maintenance and regeneration. Nat Neurosci 2007; 10:720-6; PMID:17468753; http://dx.doi.org/10.1038/nn1882.
28. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 2000; 20:4106-14; PMID:10805752; http://dx.doi.org/10.1128/MCB.20.11.4106-14.2000.
29. Trombley PQ, Westbrook GL. Voltage-gated currents in identified rat olfactory receptor neurons. J Neurosci 1991; 11:435-44; PMID:1992011.
30. Clare JJ. Targeting voltage-gated sodium channels for pain therapy. Expert Opin Investig Drugs 2010; 19:45-62; PMID:20001554; http://dx.doi.org/10. 1517/13543780903435340.
31. Fieni F, Ghiaroni V, Tirindelli R, Pietra P, Bigiani A. Apical and basal neurones isolated from the mouse vomeronasal organ differ for voltage-dependent currents. J Physiol 2003; 552:425-36; PMID:14561826; http://dx.doi.org/10.1113/ jphysiol.2003.052035.
32. Ukhanov K, Leinders-Zufall T, Zufall F. Patch-clamp analysis of gene-targeted vomeronasal neurons expressing a defined V1r or V2r receptor: ionic mechanisms underlying persistent firing. J Neurophysiol 2007; 98:2357-69; PMID:17715188; http://dx.doi.org/10.1152/jn.00642.2007.
33. Vukovic J, Blomster LV, Chinnery HR, Weninger W, Jung S, McMenamin PG, et al. Bone marrow chimeric mice reveal a role for CX3CR1 in maintenance of the monocyte-derived cell population in the olfactory neuroepithelium. J Leukoc Biol 2010; 88:645-54; PMID:20610801; http://dx.doi.org/10.1189/jlb.0410194.
34. Blomster LV, Vukovic J, Hendrickx DA, Jung S, Harvey AR, Filgueira L, et al. CX3CR1 deficiency exacerbates neuronal loss and impairs early regenerative responses in the target-ablated olfactory epithelium. Mol Cell Neurosci 2011; 48:236-45; PMID:21871566; http://dx.doi.org/10.1016/j.mcn.2011.08.004.
35. Suzuki Y, Schafer J, Farbman AI. Phagocytic cells in the rat olfactory epithelium after bulbectomy. Exp Neurol 1995; 136:225-33; PMID:7498412; http://dx.doi.org/10.1006/exnr.1995.1099.
36. Zsiros E, Kis-Toth K, Hajdu P, Gaspar R, Bielanska J, Felipe A, et al. Developmental switch of the expression of ion channels in human dendritic cells. J Immunol 2009; 183:4483-92; PMID:19748986; http://dx.doi.org/10.4049/jimmunol. 0803003.
37. Bergman U, Ostergren A, Gustafson AL, Brittebo B. Differential effects of olfactory toxicants on olfactory regeneration. Arch Toxicol 2002; 76:104-12; PMID:11914780; http://dx.doi.org/10.1007/s00204-002-0321-2.